Header Logo

Connection

Laurel Habel to Middle Aged

Back to Details
This is a "connection" page, showing publications Laurel Habel has written about Middle Aged.
Laurel Habel
Connection Strength
2.838
Middle Aged
  1. Identification of 31 loci for mammographic density phenotypes and their associations with breast cancer risk. Nat Commun. 2020 10 09; 11(1):5116.
    View in: PubMed
    Score: 0.078
  2. Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence. Breast Cancer Res Treat. 2020 Feb; 180(1):219-226.
    View in: PubMed
    Score: 0.074
  3. Blood pressure lowering medication initiation and fracture risk: a SWAN pharmacoepidemiology study. Arch Osteoporos. 2019 06 28; 14(1):73.
    View in: PubMed
    Score: 0.071
  4. Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives. Cancer Res. 2017 12 01; 77(23):6770-6776.
    View in: PubMed
    Score: 0.064
  5. Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat. 2018 02; 167(3):751-759.
    View in: PubMed
    Score: 0.063
  6. Age at Menarche and Late Adolescent Adiposity Associated with Mammographic Density on Processed Digital Mammograms in 24,840 Women. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1450-1458.
    View in: PubMed
    Score: 0.062
  7. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening. J Prim Care Community Health. 2017 Apr; 8(2):55-62.
    View in: PubMed
    Score: 0.059
  8. Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma. Br J Cancer. 2016 09 27; 115(7):895-900.
    View in: PubMed
    Score: 0.058
  9. Case-control study of mammographic density and breast cancer risk using processed digital mammograms. Breast Cancer Res. 2016 05 21; 18(1):53.
    View in: PubMed
    Score: 0.057
  10. Metformin use and lung cancer risk in patients with diabetes. Cancer Prev Res (Phila). 2015 Feb; 8(2):174-9.
    View in: PubMed
    Score: 0.052
  11. Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort. Cancer Causes Control. 2015 Mar; 26(3):431-42.
    View in: PubMed
    Score: 0.052
  12. Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system. J Clin Oncol. 2014 Jul 10; 32(20):2151-8.
    View in: PubMed
    Score: 0.050
  13. Complications of herpes zoster in cancer patients. Scand J Infect Dis. 2014 Jul; 46(7):528-32.
    View in: PubMed
    Score: 0.050
  14. Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy. Obstet Gynecol. 2014 Jan; 123(1):65-72.
    View in: PubMed
    Score: 0.048
  15. Antidepressants and testicular cancer. Cancer Causes Control. 2014 Feb; 25(2):251-8.
    View in: PubMed
    Score: 0.048
  16. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes. Diabetes Care. 2013 Dec; 36(12):3953-60.
    View in: PubMed
    Score: 0.048
  17. Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ. Breast Cancer Res Treat. 2013 Jun; 139(2):453-60.
    View in: PubMed
    Score: 0.046
  18. HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease. Breast Cancer Res. 2013 Mar 14; 15(2):R24.
    View in: PubMed
    Score: 0.046
  19. The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):82-90.
    View in: PubMed
    Score: 0.045
  20. Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med. 2012 Sep 10; 172(16):1246-51.
    View in: PubMed
    Score: 0.044
  21. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA. 2011 Dec 28; 306(24):2673-83.
    View in: PubMed
    Score: 0.042
  22. Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9.
    View in: PubMed
    Score: 0.040
  23. Metabolic syndrome and mammographic density: the Study of Women's Health Across the Nation. Int J Cancer. 2011 Oct 01; 129(7):1699-707.
    View in: PubMed
    Score: 0.040
  24. Mammographic density and risk of second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2488-95.
    View in: PubMed
    Score: 0.039
  25. Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. J Clin Oncol. 2010 Oct 01; 28(28):4300-6.
    View in: PubMed
    Score: 0.038
  26. Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans. Am J Manag Care. 2010 May; 16(5):351-60.
    View in: PubMed
    Score: 0.038
  27. Physical activity and change in mammographic density: the Study of Women's Health Across the Nation. Am J Epidemiol. 2010 May 01; 171(9):960-8.
    View in: PubMed
    Score: 0.037
  28. Active, but not passive cigarette smoking was inversely associated with mammographic density. Cancer Causes Control. 2010 Feb; 21(2):301-11.
    View in: PubMed
    Score: 0.037
  29. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol. 2009 Dec; 33(12):1802-8.
    View in: PubMed
    Score: 0.037
  30. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res. 2009; 11(6):R85.
    View in: PubMed
    Score: 0.036
  31. Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1.
    View in: PubMed
    Score: 0.034
  32. Pharmaceuticals that cause mammary gland tumors in animals: findings in women. Breast Cancer Res Treat. 2009 Jul; 116(1):187-94.
    View in: PubMed
    Score: 0.033
  33. Glycemic status and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2008 Mar; 17(3):628-35.
    View in: PubMed
    Score: 0.032
  34. Physical activity and mammographic density in a cohort of midlife women. Med Sci Sports Exerc. 2008 Mar; 40(3):451-6.
    View in: PubMed
    Score: 0.032
  35. Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN). Breast Cancer Res Treat. 2008 Nov; 112(1):165-74.
    View in: PubMed
    Score: 0.032
  36. Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf. 2007 Nov; 16(11):1195-202.
    View in: PubMed
    Score: 0.032
  37. Mammographic density in a multiethnic cohort. Menopause. 2007 Sep-Oct; 14(5):891-9.
    View in: PubMed
    Score: 0.031
  38. Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol. 2007 Nov; 20(11):1149-55.
    View in: PubMed
    Score: 0.031
  39. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res. 2006; 8(3):R25.
    View in: PubMed
    Score: 0.029
  40. Use of raloxifene among women with a history of breast cancer. Breast Cancer Res Treat. 2006 Mar; 96(2):123-9.
    View in: PubMed
    Score: 0.028
  41. Mammographic density and breast cancer after ductal carcinoma in situ. J Natl Cancer Inst. 2004 Oct 06; 96(19):1467-72.
    View in: PubMed
    Score: 0.026
  42. Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system. PLoS One. 2024; 19(6):e0303303.
    View in: PubMed
    Score: 0.025
  43. Mammographic density mediates the protective effect of early-life body size on breast cancer risk. Nat Commun. 2024 May 13; 15(1):4021.
    View in: PubMed
    Score: 0.025
  44. Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes Control. 2002 Jun; 13(5):427-34.
    View in: PubMed
    Score: 0.022
  45. Prescription medications for sleep disturbances among midlife women during 2 years of follow-up: a SWAN retrospective cohort study. BMJ Open. 2021 05 11; 11(5):e045074.
    View in: PubMed
    Score: 0.020
  46. Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts. Nat Commun. 2021 02 12; 12(1):970.
    View in: PubMed
    Score: 0.020
  47. Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
    View in: PubMed
    Score: 0.019
  48. Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort. Prostate. 2000 May 01; 43(2):136-43.
    View in: PubMed
    Score: 0.019
  49. Alcohol and Tobacco Use in Relation to Mammographic Density in 23,456 Women. Cancer Epidemiol Biomarkers Prev. 2020 05; 29(5):1039-1048.
    View in: PubMed
    Score: 0.019
  50. Risk of recurrence after ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 1998 Aug; 7(8):689-96.
    View in: PubMed
    Score: 0.017
  51. Risk factors for incident and recurrent condylomata acuminata among women. A population-based study. Sex Transm Dis. 1998 Jul; 25(6):285-92.
    View in: PubMed
    Score: 0.017
  52. Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis. Cancer Causes Control. 2018 01; 29(1):143-156.
    View in: PubMed
    Score: 0.016
  53. Hydrochlorothiazide use is strongly associated with risk of lip cancer. J Intern Med. 2017 10; 282(4):322-331.
    View in: PubMed
    Score: 0.015
  54. Statin use and risk of multiple myeloma: An analysis from the cancer research network. Int J Cancer. 2017 08 01; 141(3):480-487.
    View in: PubMed
    Score: 0.015
  55. Feasibility of collecting tumor samples of breast cancer patients diagnosed up to 50 years ago in the Child Health and Development Studies. J Dev Orig Health Dis. 2017 Jun; 8(3):331-336.
    View in: PubMed
    Score: 0.015
  56. Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN). J Am Heart Assoc. 2017 Feb 23; 6(3).
    View in: PubMed
    Score: 0.015
  57. Oncologist and organizational factors associated with variation in breast cancer multigene testing. Breast Cancer Res Treat. 2017 May; 163(1):167-176.
    View in: PubMed
    Score: 0.015
  58. Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. Nat Commun. 2017 01 31; 8:14248.
    View in: PubMed
    Score: 0.015
  59. Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surg. 1997 Jan; 225(1):69-75.
    View in: PubMed
    Score: 0.015
  60. Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22.
    View in: PubMed
    Score: 0.015
  61. Oral contraceptive use and risk of breast cancer in middle-aged women. Am J Epidemiol. 1996 Jul 15; 144(2):161-4.
    View in: PubMed
    Score: 0.014
  62. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
    View in: PubMed
    Score: 0.014
  63. Breast cancer multigene testing trends and impact on chemotherapy use. Am J Manag Care. 2016 05 01; 22(5):e153-60.
    View in: PubMed
    Score: 0.014
  64. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Res Treat. 2016 Apr; 156(2):379-89.
    View in: PubMed
    Score: 0.014
  65. A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Res. 2016 04 15; 76(8):2288-2300.
    View in: PubMed
    Score: 0.014
  66. Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community. Breast Cancer Res Treat. 2016 Feb; 155(3):541-9.
    View in: PubMed
    Score: 0.014
  67. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors. J Natl Cancer Inst. 2016 Mar; 108(3).
    View in: PubMed
    Score: 0.014
  68. Physical Activity and Risk of Male Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2015 Dec; 24(12):1898-901.
    View in: PubMed
    Score: 0.014
  69. Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. JAMA. 2015 Jul 21; 314(3):265-77.
    View in: PubMed
    Score: 0.013
  70. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S502-8.
    View in: PubMed
    Score: 0.013
  71. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Cancer Discov. 2015 Aug; 5(8):878-91.
    View in: PubMed
    Score: 0.013
  72. Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk. J Clin Oncol. 2015 Jun 20; 33(18):2041-50.
    View in: PubMed
    Score: 0.013
  73. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.013
  74. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.013
  75. Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system. Am J Public Health. 2015 May; 105(5):938-46.
    View in: PubMed
    Score: 0.013
  76. Occupation and breast cancer risk in middle-aged women. J Occup Environ Med. 1995 Mar; 37(3):349-56.
    View in: PubMed
    Score: 0.013
  77. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
    View in: PubMed
    Score: 0.013
  78. Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 2014 Nov; 21(12):3766-73.
    View in: PubMed
    Score: 0.012
  79. Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care. 2014 May; 52(5):e30-8.
    View in: PubMed
    Score: 0.012
  80. Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):636-45.
    View in: PubMed
    Score: 0.012
  81. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
    View in: PubMed
    Score: 0.012
  82. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
    View in: PubMed
    Score: 0.012
  83. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
    View in: PubMed
    Score: 0.012
  84. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative. Cancer Epidemiol Biomarkers Prev. 2013 Mar; 22(3):365-73.
    View in: PubMed
    Score: 0.011
  85. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013 Jan; 137(1):247-60.
    View in: PubMed
    Score: 0.011
  86. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33.
    View in: PubMed
    Score: 0.011
  87. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 05; 104(17):1293-305.
    View in: PubMed
    Score: 0.011
  88. Racial and ethnic differences in adjuvant hormonal therapy use. J Womens Health (Larchmt). 2012 Sep; 21(9):950-8.
    View in: PubMed
    Score: 0.011
  89. Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS. J Natl Cancer Inst. 2012 Apr 18; 104(8):614-21.
    View in: PubMed
    Score: 0.011
  90. Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):673-80.
    View in: PubMed
    Score: 0.011
  91. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012 Mar 03; 379(9818):823-32.
    View in: PubMed
    Score: 0.011
  92. Risk of cancer in patients exposed to gabapentin in two electronic medical record systems. Pharmacoepidemiol Drug Saf. 2012 Feb; 21(2):214-25.
    View in: PubMed
    Score: 0.011
  93. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(2):607-17.
    View in: PubMed
    Score: 0.010
  94. Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Cancer Causes Control. 2011 Oct; 22(10):1415-24.
    View in: PubMed
    Score: 0.010
  95. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
    View in: PubMed
    Score: 0.010
  96. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat. 2011 Sep; 129(2):549-56.
    View in: PubMed
    Score: 0.010
  97. A method to estimate off-schedule observations in a longitudinal study. Ann Epidemiol. 2011 Apr; 21(4):297-303.
    View in: PubMed
    Score: 0.010
  98. Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3027-36.
    View in: PubMed
    Score: 0.010
  99. Lipophilic statin use and risk of breast cancer subtypes. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2479-87.
    View in: PubMed
    Score: 0.010
  100. Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs. 2009 Jul 30; 69(11):1445-57.
    View in: PubMed
    Score: 0.009
  101. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. Breast Cancer Res. 2009; 11(4):R51.
    View in: PubMed
    Score: 0.009
  102. Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009 Jul 01; 27(19):3211-6.
    View in: PubMed
    Score: 0.009
  103. Longitudinal association of anthropometry with mammographic breast density in the Study of Women's Health Across the Nation. Int J Cancer. 2009 Mar 01; 124(5):1169-77.
    View in: PubMed
    Score: 0.009
  104. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8.
    View in: PubMed
    Score: 0.008
  105. Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004.
    View in: PubMed
    Score: 0.008
  106. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter. 2008 Oct; 13(5):352-60.
    View in: PubMed
    Score: 0.008
  107. Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102.
    View in: PubMed
    Score: 0.008
  108. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 2008 Apr 16; 100(8):563-71.
    View in: PubMed
    Score: 0.008
  109. Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2218-25.
    View in: PubMed
    Score: 0.008
  110. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut. 2008 Jun; 57(6):727-33.
    View in: PubMed
    Score: 0.008
  111. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
    View in: PubMed
    Score: 0.008
  112. Correlates of screening sigmoidoscopy use among men in a large nonprofit health plan. Cancer. 2007 Jul 15; 110(2):275-81.
    View in: PubMed
    Score: 0.008
  113. The association between mammographic breast density and bone mineral density in the study of women's health across the nation. Ann Epidemiol. 2007 Aug; 17(8):575-83.
    View in: PubMed
    Score: 0.008
  114. Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. Menopause. 2007 May-Jun; 14(3 Pt 1):391-6.
    View in: PubMed
    Score: 0.008
  115. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311.
    View in: PubMed
    Score: 0.008
  116. NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007 Aug; 18(6):613-20.
    View in: PubMed
    Score: 0.008
  117. California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting. BMC Public Health. 2006 Jun 30; 6:172.
    View in: PubMed
    Score: 0.007
  118. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44.
    View in: PubMed
    Score: 0.007
  119. Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat. 2006 Sep; 99(1):47-57.
    View in: PubMed
    Score: 0.007
  120. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol. 2004 May; 68(1):57-69.
    View in: PubMed
    Score: 0.006
  121. Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol. 2002 Oct; 12(7):469-75.
    View in: PubMed
    Score: 0.006
  122. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar; 122(3):633-40.
    View in: PubMed
    Score: 0.005
  123. Risk factors for incident and recurrent condylomata acuminata among men. A population-based study. Sex Transm Dis. 1998 Jul; 25(6):278-84.
    View in: PubMed
    Score: 0.004
  124. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA. 1995 Jul 12; 274(2):137-42.
    View in: PubMed
    Score: 0.003
  125. Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study Group. Vox Sang. 1990; 59(3):129-35.
    View in: PubMed
    Score: 0.002

© 2024 Kaiser Permanente